FOLH1 and posterior cortical atrophy: In restaging PCa patients with negative conventional imaging for men for whom salvage therapy is contemplated, PET/CT or PET/MRI with different radiopharmaceuticals (including PSMA-targeted agents or radiolabeled Cho or 18F-FACBC or 18F-NaF) is recommended as they have superior disease detection performance characteristics and may alter patient management [1].